Company
Headquarters: Olaine, Latvia
Employees: 2,191
€122.5 Million
EUR as of Dec. 1, 2021
US$138.5 Million
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
AS Olainfarm manufactures and distributes chemical and pharmaceutical products in Latvia. The company operates through five segments: Manufacturing of Medicines, Wholesale, Retail Sale, Compression Products, and Other. It provides over the counter products, including medicines for anti-allergy, anti-inflammatory and analgesic, antibacterial, common cold, and digestive systems; and prescription medicines for antibacterial, digestive systems, metabolic, antifungal, and antiviral, as well as for cardiovascular health and nervous systems; and food supplements. The company also offers active pharmaceutical ingredients (APIs) and intermediates; pharmacovigilance services; and QC/QA, regulatory, APIs and intermediates development, final dosage forms development, and contract manufacturing services. In addition, it engages in the sale of medicine and other products to retailers; operation of a pharmacy chain under the Latvijas Aptieka name; production and sale of elastic and compression materials, food supplements, ecological pharmaceuticals and food additives, herbal teas and infusions, and ecological cosmetics; and provision of travelling, cosmetics distribution, marketing, investment property, and public services. The company also exports its products to approximately 60 countries. AS Olainfarm was founded in 1972 and is based in Olaine, Latvia. As of December 7, 2021, AS Olainfarm operates as a subsidiary of AS "AB CITY".
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Olainfarm AS has the following listings and related stock indices.
Stock: FSX: UU4 wb_incandescent